Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Surgical Procedure
|
| gptkbp:allocationSystem |
MELD score
PELD score |
| gptkbp:canBe |
Adult
Pediatric Deceased donor Living donor Domino transplant Orthotopic Split liver |
| gptkbp:contraindication |
Metastatic cancer
Active substance abuse Severe heart or lung disease Uncontrolled infection |
| gptkbp:firstPerformed |
gptkb:Thomas_Starzl
1963 |
| gptkbp:followedBy |
Lifelong medical follow-up
|
| https://www.w3.org/2000/01/rdf-schema#label |
Liver Transplantation
|
| gptkbp:improves |
Survival in liver failure
|
| gptkbp:indication |
gptkb:Hepatitis_B
gptkb:Hepatitis_C Liver cancer Cirrhosis Acute liver failure Alcoholic liver disease Biliary atresia Non-alcoholic fatty liver disease |
| gptkbp:performedAt |
Specialized transplant centers
|
| gptkbp:performedBy |
Transplant surgeon
|
| gptkbp:regulates |
NHS Blood and Transplant (UK)
UNOS (United States) |
| gptkbp:relatedTo |
gptkb:Hepatology
Surgery Organ donation Transplant immunology |
| gptkbp:requires |
Immunosuppression
Donor liver Post-transplant care Pre-transplant evaluation |
| gptkbp:riskFactor |
Rejection
Bleeding Infection Bile duct complications Graft failure |
| gptkbp:survivalRate |
1-year survival >85%
5-year survival ~70% |
| gptkbp:usedFor |
Treatment of acute liver failure
Treatment of end-stage liver disease |
| gptkbp:bfsParent |
gptkb:American_Association_for_the_Study_of_Liver_Diseases
|
| gptkbp:bfsLayer |
7
|